首页 › 基金 › ORBIMED ADVISORS LLC › EW
ORBIMED ADVISORS LLC 对 EW 的持仓历史
EDWARDS LIFESCIENCES CORP · 医疗保健
ORBIMED ADVISORS LLC 在 Q2 2026 的 13F 申报中披露持有 EW(EDWARDS LIFESCIENCES CORP)834,900 股,市值约 US$75.5M,约占其申报组合的 1.52%,在其申报持仓中市值排名第 16 位。 ORBIMED ADVISORS LLC 最近 7 个申报季度中有 7 个季度披露了 EW 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
ORBIMED ADVISORS LLC 对 EW 的持仓演变
ORBIMED ADVISORS LLC 于 Q4 2024 首次披露 EW 持仓:1,145,302 股(约 US$84.8M)。 该持仓在 Q2 2025 达到峰值 1,708,000 股,市值约 US$133.6M。 在 7 次申报中,ORBIMED ADVISORS LLC 3 次增持、3 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 834,900 股、市值约 US$75.5M,环比减持 -395,700 股。。 持仓曾出现大幅变动:Q1 2025 增持约 34% (随后一个季度股价上涨 8%)、Q4 2025 减持约 91% (随后一个季度股价下跌 6%)、Q1 2026 增持约 720% (随后一个季度股价上涨 13%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 1.15M | $84.79M | 新进 |
| Q1 2025 | 1.53M | $111.04M | 增持 |
| Q2 2025 | 1.71M | $133.58M | 增持 |
| Q3 2025 | 1.68M | $130.96M | 减持 |
| Q4 2025 | 150.00K | $12.79M | 减持 |
| Q1 2026 | 1.23M | $98.55M | 增持 |
| Q2 2026 | 834.90K | $75.53M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 EW 与 13F 数据
EW(EDWARDS LIFESCIENCES CORP)属于医疗保健行业。我们追踪的基金中还有 34 只申报持有 EW,申报仓位最大的包括:DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 EW 的基金
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 13.00M 股 · $1.18B · Q2 2026
- Ninety One UK Ltd 11.94M 股 · $1.03B · Q3 2026
- Aristotle Capital Management, LLC 8.67M 股 · $783.91M · Q2 2026
- BROWN ADVISORY INC 7.37M 股 · $666.33M · Q2 2026
- Artisan Partners Limited Partnership 6.63M 股 · $599.36M · Q2 2026
- WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 4.80M 股 · $434.21M · Q2 2026
更多关于 ORBIMED ADVISORS LLC
常见问题
How long has ORBIMED ADVISORS LLC held EW?
ORBIMED ADVISORS LLC has disclosed EW holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is ORBIMED ADVISORS LLC's current position in EW?
As of Q2 2026, ORBIMED ADVISORS LLC holds 834.90K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $75.53M, representing 1.52% of its reported portfolio and ranking #16.
Has ORBIMED ADVISORS LLC been buying or selling EW?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC reduced its position in EW. The position peaked in Q2 2025 at 1.71M shares.
Which other funds hold EW?
Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.